Mohammad Kermansaravi
Overview
Explore the profile of Mohammad Kermansaravi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dean Y, Mohamed M, Shokri A, Nassar M, Omayer A, Shahid M, et al.
Obes Surg
. 2025 Feb;
PMID: 40000567
Background: Studies have discussed the efficacy of bariatric surgery (BS) in remission of individual components of metabolic syndrome (MS). We aimed to analyse the prevalence of MS following BS. Methods:...
2.
Kermansaravi M, Shahsavan M, Hage K, Taskin H, ShahabiShahmiri S, Poghosyan T, et al.
Surg Endosc
. 2025 Feb;
39(3):1509-1522.
PMID: 39930123
Background: One anastomosis gastric bypass (OAGB) currently stands as the third most common metabolic and bariatric surgical procedure with increasing popularity worldwide. Iron deficiency anemia (IDA) is the most prevalent...
3.
Shahmiri S, Esparham A, Sedaghat H, Safari S, Daryabari S, Pazouki A, et al.
Obes Surg
. 2025 Jan;
35(2):525-534.
PMID: 39776045
Background: Previous studies showed a high conversion rate and failure of restrictive procedures, including sleeve gastrectomy (SG), adjustable gastric banding (AGB), gastric plication (GP), and vertical banded gastroplasty (VBG) in...
4.
Safari S, Ekramnia I, Chehresonboll Y, Ahmadi V, Kermansaravi M
Sci Rep
. 2024 Dec;
14(1):31012.
PMID: 39730809
Roux-en-Y gastric bypass (RYGB) is the second most common metabolic and bariatric surgery (MBS) globally. The impact of pouch size on weight loss outcomes and complications remains unclear. This study...
5.
Shahmiri S, Pazouki A, Jazi A, Safari S, Mahjoubi M, Sheikhbahaei E, et al.
Obes Surg
. 2024 Dec;
35(1):102-111.
PMID: 39674852
Background: While OAGB shows promise in the short to medium term, its long-term durability, weight trends, blood levels of metabolic factors and nutrients, and potential complications require further exploration through...
6.
Clyde D, Adib R, Baig S, Bhasker A, Byrne J, Cameron D, et al.
Clin Obes
. 2024 Dec;
15(2):e12722.
PMID: 39673462
Global obesity rates have risen dramatically, now exceeding deaths from starvation. Metabolic and bariatric surgery (MBS), initially for severe obesity (BMI ≥35 kg/m), is performed globally over 500 000 times...
7.
Cohen R, Park J, Prager G, Bueter M, le Roux C, Parmar C, et al.
Br J Surg
. 2024 Nov;
111(12).
PMID: 39612581
No abstract available.
8.
Farzadmanesh M, Shahsavan M, Shahmiri S, Ghorbani M, Fathi M, Mehrnia N, et al.
Obes Surg
. 2024 Nov;
35(1):78-86.
PMID: 39602014
Background: Bile reflux (BR) is an issue after one anastomosis gastric bypass (OAGB). Cholecystectomy can increase BR in patients without a history of metabolic and bariatric surgery. We aimed to...
9.
Athar R, Shahsavan M, Shahabi S, Pazouki A, Husain F, Kermansaravi M
Surg Laparosc Endosc Percutan Tech
. 2024 Nov;
35(1).
PMID: 39588751
Background: Obesity-associated nonalcoholic fatty liver disease (NAFLD) is a significant cause of chronic liver disease. Our study sought to investigate preoperative NAFLD and the effect at 6 months and 2...
10.
Kermansaravi M, Chiappetta S, Kassir R, Bosco A, Giudicelli X, Lainas P, et al.
Obes Surg
. 2024 Nov;
34(12):4555-4562.
PMID: 39496986
The worldwide prevalence of type 2 diabetes mellitus (T2DM) is increasing in parallel with obesity. One anastomosis gastric bypass (OAGB) is considered effective to treat both T2DM and obesity. The...